BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 38642705)

  • 1. Management of abnormal uterine bleeding on anticoagulation: the patient-clinician perspective.
    Samuelson Bannow BT
    J Thromb Haemost; 2024 Apr; ():. PubMed ID: 38642705
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Management of heavy menstrual bleeding during direct oral anticoagulant therapy for recurrent venous thromboembolism: a case report.
    Giustozzi M; Vedovati MC; Agnelli G
    Blood Coagul Fibrinolysis; 2018 Jun; 29(4):391-394. PubMed ID: 29346128
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anticoagulant therapy for women: implications for menstruation, pregnancy, and lactation.
    DeLoughery E; Bannow BS
    Hematology Am Soc Hematol Educ Program; 2022 Dec; 2022(1):467-473. PubMed ID: 36485151
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heavy menstrual bleeding in women treated with rivaroxaban and vitamin K antagonists and the risk of recurrent venous thromboembolism.
    Bryk AH; Piróg M; Plens K; Undas A
    Vascul Pharmacol; 2016 Dec; 87():242-247. PubMed ID: 27865826
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Menstruation, anticoagulation, and contraception: VTE and uterine bleeding.
    Samuelson Bannow B; McLintock C; James P
    Res Pract Thromb Haemost; 2021 Jul; 5(5):e12570. PubMed ID: 34368613
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Do women with venous thromboembolism bleed more than men during anticoagulation? Data from the real-life, prospective START-Register.
    Palareti G; Legnani C; Antonucci E; Cosmi B; Falanga A; Poli D; Mastroiacovo D; Pengo V; Ageno W; Testa S
    Ther Adv Drug Saf; 2021; 12():20420986211062965. PubMed ID: 34987749
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Abnormal uterine bleeding in VTE patients treated with rivaroxaban compared to vitamin K antagonists.
    De Crem N; Peerlinck K; Vanassche T; Vanheule K; Debaveye B; Middeldorp S; Verhamme P; Peetermans M
    Thromb Res; 2015 Oct; 136(4):749-53. PubMed ID: 26272306
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bleeding Issues in Women Under Oral Anticoagulation.
    Kalmanti L; Lindhoff-Last E
    Hamostaseologie; 2022 Oct; 42(5):337-347. PubMed ID: 36323281
    [TBL] [Abstract][Full Text] [Related]  

  • 9. How I treat heavy menstrual bleeding associated with anticoagulants.
    Boonyawat K; O'Brien SH; Bates SM
    Blood; 2017 Dec; 130(24):2603-2609. PubMed ID: 29092828
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Review of Clinical Guidelines on the Management of Iron Deficiency and Iron-Deficiency Anemia in Women with Heavy Menstrual Bleeding.
    Mansour D; Hofmann A; Gemzell-Danielsson K
    Adv Ther; 2021 Jan; 38(1):201-225. PubMed ID: 33247314
    [TBL] [Abstract][Full Text] [Related]  

  • 11. From menarche to menopause, heavy menstrual bleeding is the underrated compass in reproductive health.
    Vannuccini S; Jain V; Critchley H; Petraglia F
    Fertil Steril; 2022 Oct; 118(4):625-636. PubMed ID: 36075746
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Abnormal uterine bleeding in anticoagulated patients by drug class: outcomes and management.
    Brioso XB; Bolt M; Sammel MD; McKenney K
    Am J Obstet Gynecol; 2023 Sep; 229(3):318.e1-318.e14. PubMed ID: 37201695
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral contraception and menstrual bleeding during treatment of venous thromboembolism: Expert opinion versus current practice: Combined results of a systematic review, expert panel opinion and an international survey.
    Klok FA; Schreiber K; Stach K; Ageno W; Middeldorp S; Eichinger S; Delluc A; Blondon M; Ay C
    Thromb Res; 2017 May; 153():101-107. PubMed ID: 28376343
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systematic review and meta-analysis of the etiology of heavy menstrual bleeding in 2,770 adolescent females.
    Hall EM; Ravelo AE; Aronoff SC; Del Vecchio MT
    BMC Womens Health; 2024 Feb; 24(1):136. PubMed ID: 38378571
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Progesterone or progestogen-releasing intrauterine systems for heavy menstrual bleeding.
    Lethaby A; Hussain M; Rishworth JR; Rees MC
    Cochrane Database Syst Rev; 2015 Apr; (4):CD002126. PubMed ID: 25924648
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of heavy menstrual bleeding in general practice.
    Fox KE
    Curr Med Res Opin; 2012 Sep; 28(9):1517-25. PubMed ID: 22834901
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heavy menstrual bleeding: work-up and management.
    James AH
    Hematology Am Soc Hematol Educ Program; 2016 Dec; 2016(1):236-242. PubMed ID: 27913486
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Progestogen-releasing intrauterine systems for heavy menstrual bleeding.
    Bofill Rodriguez M; Lethaby A; Jordan V
    Cochrane Database Syst Rev; 2020 Jun; 6(6):CD002126. PubMed ID: 32529637
    [TBL] [Abstract][Full Text] [Related]  

  • 19. How do anticoagulants impact menstrual bleeding and quality of life? - The PERIOD study.
    Patel JP; Nzelu O; Roberts LN; Johns J; Ross J; Arya R
    Res Pract Thromb Haemost; 2023 Feb; 7(2):100072. PubMed ID: 36861116
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Uterine bleeding during anticoagulation in women with venous thromboembolism.
    Moustafa F; Fernández S; Fernández-Capitán C; Nieto JA; Pedrajas JM; Visoná A; Valero B; Marchena PJ; Braester A; Monreal M;
    Thromb Res; 2017 Mar; 151 Suppl 1():S1-S5. PubMed ID: 28262225
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.